Wei Wang

Dr. Wei Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2022 in Kidney International
Verified
Journal Article
Closed access
JYJu-Tao Yu
Ju-Tao Yu
XHXiao-Wei Hu
Xiao-Wei Hu
QYQin Yang
Qin Yang
RSRun-Run Shan
Run-Run Shan
YZYao Zhang
Yao Zhang
XMXiao-ming Meng
Xiao-ming Meng

1 May 2021 in Life Sciences
Verified
Journal Article
Closed access
HYHonglin Yu
Honglin Yu
JZJingbo Zhu
Jingbo Zhu
LCLingyu Chang
Lingyu Chang
CLChaozhao Liang
Chaozhao Liang
XLXiaohu Li
Xiaohu Li
WWWei Wang
Wei Wang

17 July 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JYJu-Tao Yu
Ju-Tao Yu
SFShuai Fan
Shuai Fan
XLXiang-Yu Li
Xiang-Yu Li
RHRui Hou
Rui Hou
XHXiao-Wei Hu
Xiao-Wei Hu
XMXiao-ming Meng
Xiao-ming Meng
Signal transducer and activator of transcription 3 (STAT3) is a cell-signal transcription factor that has attracted considerable attention in recent years. The stimulation of cytokines and growth factors can result in the transcription of a wide range of genes that are crucial for several cellular biological processes involved in pro- and anti-inflammatory responses. STAT3 has attracted considerable interest as a result of a recent upsurge in study because of their role in directing the innate immune response and sustaining inflammatory pathways, which is a key feature in the pathogenesis of many diseases, including renal disorders. Several pathological conditions which may involve STAT3 include diabetic nephropathy, acute kidney injury, lupus nephritis, polycystic kidney disease, and renal cell carcinoma. STAT3 is expressed in various renal tissues under these pathological conditions. To better understand the role of STAT3 in the kidney and provide a theoretical foundation for STAT3-targeted therapy for renal disorders, this review covers the current work on the activities of STAT3 and its mechanisms in the pathophysiological processes of various types of renal diseases.

4 March 2025 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
YXYuexian Xu
Yuexian Xu
GLGuoxiang Li
Guoxiang Li
WLWanqing Liu
Wanqing Liu
DGDefeng Ge
Defeng Ge
ZHZongyao Hao
Zongyao Hao
WWWei Wang
Wei Wang

29 March 2025 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
YXYuexian Xu
Yuexian Xu
JYJianmin You
Jianmin You
JYJunfeng Yao
Junfeng Yao
BHBingBing Hou
BingBing Hou
WWWei Wang
Wei Wang
ZHZongyao Hao
Zongyao Hao

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
XZXiaojie Zhao
Xiaojie Zhao
DWDan Wang
Dan Wang
SWShanshan Wan
Shanshan Wan
XLXiuheng Liu
Xiuheng Liu
WWWei Wang
Wei Wang
LWLei Wang
Lei Wang
Background. Pin1, as the peptidyl‐prolyl isomerase, plays a vital role in cellular processes. However, whether it has a regulatory effect on renal ischemia and reperfusion (I/R) injury still remains unknown. Methods. The hypoxia/reoxygenation (H/R) model in human kidney (HK‐2) cells and the I/R model in rats were assessed to investigate the role of Pin1 on I/R‐induced acute kidney injury. Male Sprague‐Dawley rats were used to establish the I/R model for 15, 30, and 45 min ischemia and then 24 h reperfusion, with or without the Pin1 inhibitor, to demonstrate the role of Pin1 in acute kidney injury. HK‐2 cells were cultured and experienced the H/R model to identify the molecular mechanisms involved. Results. In this study, we found that Pin1 and oxidative stress were obviously increased after renal I/R. Inhibition of Pin1 with juglone decreased renal structural and functional injuries, as well as oxidative stress. Besides, Pin1 inhibition with the inhibitor, juglone, or the small interfering RNA showed significant reduction on oxidative stress markers caused by the H/R process in vitro. Furthermore, the results indicated that the expression of p38 MAPK was increased during H/R in vitro and Pin1 inhibition could reduce the increased expression of p38 MAPK. Conclusion. Our results illustrated that Pin1 aggravated renal I/R injury via elevating oxidative stress through activation of the p38 MAPK pathway. These findings indicated that Pin1 might become the potential treatment for renal I/R injury.